Michael Tachezy

2.6k total citations
69 papers, 1.8k citations indexed

About

Michael Tachezy is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael Tachezy has authored 69 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 28 papers in Surgery and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael Tachezy's work include Pancreatic and Hepatic Oncology Research (20 papers), Esophageal Cancer Research and Treatment (15 papers) and Cancer Cells and Metastasis (13 papers). Michael Tachezy is often cited by papers focused on Pancreatic and Hepatic Oncology Research (20 papers), Esophageal Cancer Research and Treatment (15 papers) and Cancer Cells and Metastasis (13 papers). Michael Tachezy collaborates with scholars based in Germany, United States and Sweden. Michael Tachezy's co-authors include Jakob R. Izbicki, Florian Gebauer, Maximilian Bockhorn, Yogesh K. Vashist, Hilke Zander, Klaus Pantel, Matthias Reeh, Emre F. Yekebas, Jussuf T. Kaifi and Guido Sauter and has published in prestigious journals such as PLoS ONE, Annals of Surgery and Scientific Reports.

In The Last Decade

Michael Tachezy

66 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Tachezy Germany 26 1.1k 603 574 547 477 69 1.8k
Yoshitaka Honma Japan 22 952 0.8× 591 1.0× 776 1.4× 674 1.2× 878 1.8× 170 2.3k
Stefan B. Hosch Germany 22 913 0.8× 1.1k 1.9× 916 1.6× 330 0.6× 422 0.9× 54 2.3k
Marta Salido Spain 27 1.3k 1.1× 249 0.4× 758 1.3× 683 1.2× 709 1.5× 111 2.5k
Sebastian Mannweiler Austria 21 755 0.7× 510 0.8× 793 1.4× 438 0.8× 360 0.8× 46 1.9k
Marcus Tan United States 19 1.1k 1.0× 339 0.6× 386 0.7× 264 0.5× 306 0.6× 52 1.8k
Eliane Mery-Lamarche France 23 579 0.5× 421 0.7× 231 0.4× 471 0.9× 333 0.7× 64 1.7k
Essel Dulaimi United States 25 651 0.6× 517 0.9× 682 1.2× 536 1.0× 1.4k 3.0× 56 2.5k
Caroline S. Verbeke United Kingdom 24 1.7k 1.4× 909 1.5× 554 1.0× 409 0.7× 462 1.0× 46 2.3k
Nancy Kemeny United States 20 1.8k 1.6× 834 1.4× 375 0.7× 355 0.6× 578 1.2× 32 2.4k
Christian Kurzeder Germany 25 709 0.6× 589 1.0× 225 0.4× 290 0.5× 363 0.8× 88 2.0k

Countries citing papers authored by Michael Tachezy

Since Specialization
Citations

This map shows the geographic impact of Michael Tachezy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Tachezy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Tachezy more than expected).

Fields of papers citing papers by Michael Tachezy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Tachezy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Tachezy. The network helps show where Michael Tachezy may publish in the future.

Co-authorship network of co-authors of Michael Tachezy

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Tachezy. A scholar is included among the top collaborators of Michael Tachezy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Tachezy. Michael Tachezy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reeh, Matthias, Jürgen Treckmann, Jakob R. Izbicki, et al.. (2024). Risk Factor Analysis for Developing Major Complications Following Esophageal Surgery—A Two-Center Study. Journal of Clinical Medicine. 13(4). 1137–1137. 3 indexed citations
2.
Sauerbeck, Julia, Philipp Busch, Nathaniel Melling, et al.. (2023). Minimally invasive intrathoracic negative-pressure therapy and flexible thoracoscopy (FlexVATS) for patients with pleural empyema. Scientific Reports. 13(1). 10869–10869. 2 indexed citations
3.
Reeh, Matthias, et al.. (2023). Intrathoracic vacuum therapy for the therapy of pleural empyema—a systematic review and analysis of the literature. Journal of Thoracic Disease. 15(2). 780–790. 4 indexed citations
4.
Tachezy, Michael, Tarik Ghadban, Jakob R. Izbicki, et al.. (2022). Completion of FLOT Therapy, Regardless of Tumor Regression, Significantly Improves Overall Survival in Patients with Esophageal Adenocarcinoma. Cancers. 14(4). 1084–1084. 4 indexed citations
5.
Grupp, Katharina, Tarik Ghadban, Michael Tachezy, et al.. (2021). Increased lysophosphatidylcholine acyltransferase 1 expression is unrelated to prognosis of esophageal cancer patients. Journal of Cancer Research and Clinical Oncology. 147(10). 2879–2884. 1 indexed citations
6.
Kempski, Jan, Anastasios D. Giannou, Matthias Reeh, et al.. (2020). Systemic interleukin 10 levels indicate advanced stages while interleukin 17A levels correlate with reduced survival in esophageal adenocarcinomas. PLoS ONE. 15(4). e0231833–e0231833. 9 indexed citations
7.
Kempski, Jan, Anastasios D. Giannou, Penelope Pelczar, et al.. (2020). Anti-inflammatory microenvironment of esophageal adenocarcinomas negatively impacts survival. Cancer Immunology Immunotherapy. 69(6). 1043–1056. 14 indexed citations
8.
Melling, Nathaniel, et al.. (2019). Protein expression of close homologue of L1 (CHL1) is a marker for overall survival in non-small cell lung cancer (NSCLC). Journal of Cancer Research and Clinical Oncology. 145(9). 2285–2292. 8 indexed citations
9.
Izbicki, Jakob R., et al.. (2019). A hairy cavity: endoscopic therapy of a presacral recurrence of a complex pilonidal sinus. International Journal of Colorectal Disease. 34(10). 1791–1794.
10.
Tachezy, Michael & Jakob R. Izbicki. (2019). Evidenz für chirurgische Standardverfahren: Appendizitis, Divertikulitis und Cholezystitis. Der Chirurg. 90(5). 351–356. 2 indexed citations
11.
Ghadban, Tarik, Leonie Konczalla, Kai Bachmann, et al.. (2019). Comparison of the 8th UICC staging system for esophageal and gastric cancers in Siewert type II junctional adenocarcinomas. European Journal of Surgical Oncology. 46(4). 638–643. 9 indexed citations
12.
Effenberger, Katharina E., Cornelia Schroeder, Annkathrin Hanssen, et al.. (2018). Improved Risk Stratification by Circulating Tumor Cell Counts in Pancreatic Cancer. Clinical Cancer Research. 24(12). 2844–2850. 79 indexed citations
13.
Wachowiak, Robin, Steffi Mayer, Jussuf T. Kaifi, et al.. (2016). Prognostic Impact of Activated Leucocyte Cell Adhesion Molecule (ALCAM/CD166) in Infantile Neuroblastoma.. PubMed. 36(8). 3991–5. 7 indexed citations
14.
Clauditz, Till S., Patrick Lebok, Sarah Minner, et al.. (2014). Activated leukocyte cell adhesion molecule (ALCAM/CD166) expression in head and neck squamous cell carcinoma (HNSSC). Pathology - Research and Practice. 210(10). 649–655. 14 indexed citations
15.
16.
Hofmann, Bianca T., Thorsten Dohrmann, Cenap Güngör, et al.. (2014). ABO Blood Group IgM Isoagglutinins Interact with Tumor-Associated O-Glycan Structures in Pancreatic Cancer. Clinical Cancer Research. 20(23). 6117–6126. 26 indexed citations
17.
18.
Tachezy, Michael, Katharina E. Effenberger, Hilke Zander, et al.. (2011). ALCAM (CD166) expression and serum levels are markers for poor survival of esophageal cancer patients. International Journal of Cancer. 131(2). 396–405. 42 indexed citations
19.
20.
Vashist, Yogesh K., et al.. (2010). Glasgow Prognostic Score is a Predictor of Perioperative and Long-term Outcome in Patients with only Surgically Treated Esophageal Cancer. Annals of Surgical Oncology. 18(4). 1130–1138. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshitaka Honma Breakdown of academic impact, for papers by Stefan B. Hosch Breakdown of academic impact, for papers by Marta Salido Breakdown of academic impact, for papers by Sebastian Mannweiler Breakdown of academic impact, for papers by Marcus Tan Breakdown of academic impact, for papers by Eliane Mery-Lamarche Breakdown of academic impact, for papers by Essel Dulaimi Breakdown of academic impact, for papers by Caroline S. Verbeke Breakdown of academic impact, for papers by Nancy Kemeny Breakdown of academic impact, for papers by Christian Kurzeder
Rankless by CCL
2026